ArticleCase reports in ophthalmology
A Sudden Rise of Patients with Acute Macular Neuroretinopathy during the COVID-19 Pandemic.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review.International ophthalmology · 2024Pooled it
- Acute macular neuroretinopathy: is the name still appropriate?Medical hypothesis, discovery & innovation ophthalmology journal · 2026Review
- Article
- Acute macular neuroretinopathy following COVID-19 infection: Three case reports.World journal of clinical cases · 2024Article
- Outer Retinopathies Associated with COVID-19 Infection: Case Reports and Review of Literature.Case reports in ophthalmological medicine · 2024Article
- Acute macular neuroretinopathy and COVID-19 or SARS-CoV-2 infection: case report and literature review.Frontiers in medicine · 2024Article
- Acute Macular Neuroretinopathy after SARS-CoV-2 Infection: An Analysis of Clinical and Multimodal Imaging Characteristics.Diagnostics (Basel, Switzerland) · 2023Article
- Acute macular neuroretinopathy following Moderna COVID-19 vaccination.Journal of ophthalmic inflammation and infection · 2023Article
- Coincident Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in COVID-19.Turkish journal of ophthalmology · 2023Article
- In the Eye of the Cytokine Storm: A Tale of SARS-CoV-2-Induced Acute Macular Neuroretinopathy.Cureus · 2023Article
- Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy during SARS-CoV-2 Infection and Vaccination.Vaccines · 2023Article
- COVID-19 Related Acute Macular Neuroretinopathy (AMN): A Case Series.International medical case reports journal · 2023Article
- Acute macular neuroretinopathy and COVID-19 vaccination: Case report and literature review.Journal francais d'ophtalmologie · 2023Review
- Transient Increase in Patient Numbers with "Acute Macular Neuroretinopathy" Post SARS-CoV-2 Infection-Case Series During the First Surge of Infection in December 2022.Journal of inflammation research · 2023Article
- COVID-19 and Acute Macular Neuroretinopathy - An underlying association?Annals of medicine and surgery (2012) · 2022Article
- Choroidal Circulatory and Vascular Morphological Changes in Acute Macular Neuroretinopathy After Infection With Severe Acute Respiratory Syndrome Coronavirus 2: A Case Report With Literature Review.In vivo (Athens, Greece)Review
- Bilateral Serous Detachments with Roth Spots after COVID-19 Vaccination: A Case Report.Case reports in ophthalmologyArticle
- Atypical COVID-19-Related Acute Macular Neuroretinopathy with Progression Resulting in Severe Vision Loss.Case reports in ophthalmologyArticle
- Orbital Inflammation and Dacryoadenitis after COVID-19 Vaccination.Case reports in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this paper is to inform on the surge of cases of acute macular neuroretinopathy (AMN) - a rare disease characterized by the sudden onset of acute scotomas caused by ischemia of the retinal capillary plexus - during the COVID-19 pandemic. In 2021, during the COVID-19 pandemic, a sudden rise in patients with AMN was observed in our clinic. In this paper, 4 cases from a hospital in the south of the Netherlands are reported, all of which could directly be linked to a COVID-19 infection or vaccination against the corona virus. A search for similar cases in the PubMed database produced thirteen relevant reports, which revealed that a similar increase in cases of AMN, all linked to COVID-19, has been observed worldwide. Analysis of the literature revealed that AMN is seen more often during the pandemic and that AMN after COVID-19 happens at a significantly older age than typically reported. This is the largest case series of patients with AMN after COVID-19 infection or vaccination. With the ongoing pandemic and extensive vaccination programs, it is expected that cases of AMN will surge. It is important for ophthalmologists to be aware of this disease, especially since typical patient characteristics may differ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.